sodium thiosulfate has been researched along with carboplatin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Elferink, F; Klein, I; Pinedo, HM; van der Vijgh, WJ | 1 |
| Brummett, RE; Guitjens, S; Kroll, RA; McCormick, CI; Muldoon, LL; Neuwelt, EA; Pagel, MA; Remsen, LG | 1 |
| Brummett, RE; Bubalo, JS; Church, V; Dojan, R; Doolittle, ND; Kroll, RA; Muldoon, LL; Neuwelt, EA; Pagel, MA; Remsen, LG | 1 |
| Brummett, RE; Doolittle, ND; Egorin, MJ; Kroll, RA; Muldoon, LL; Neuwelt, EA; Pagel, MA; Zuhowski, EG | 1 |
| Bennett, LC; Hale, C; Muldoon, LL; Neuwelt, EA; Purcell, SE; Walker-Rosenfeld, SL | 1 |
| Brummett, RE; Bubalo, JS; Doolittle, ND; Heinrich, MC; Henry, JA; Kraemer, DF; Lacy, C; Muldoon, LL; Neuwelt, EA; Tyson, RM | 1 |
| Blakley, BW; Campbell, KC; Cohen, JI; Dickey, DT; Doolittle, ND; Muldoon, LL; Neuwelt, EA | 1 |
| Doolittle, ND; Gilmer-Knight, K; Hornig, GW; Kraemer, DF; Lacy, C; Muldoon, LL; Neuwelt, EA; Nicholson, HS | 1 |
| Skinner, R | 1 |
| Harned, TM; Iovine, P; Ji, L; Kalous, O; Loera, J; Neuwelt, A; Neuwelt, EA; Reynolds, CP; Sposto, R | 1 |
| Cheng, J; Mitchelson, K; Wang, L; Xie, F; Xing, W; Xu, Y | 1 |
| Levine, EA; Loggie, BL; Russell, GB; Shen, P; Stewart, JH; Votanopoulos, KI | 1 |
| Freyer, DR; Knight, K; Krailo, M; Orgel, E | 1 |
1 review(s) available for sodium thiosulfate and carboplatin
| Article | Year |
|---|---|
Special considerations in the design and implementation of pediatric otoprotection trials.
Topics: Antineoplastic Agents; Cancer Survivors; Carboplatin; Child; Cisplatin; Hearing Loss; Humans; Quality of Life | 2023 |
12 other study(ies) available for sodium thiosulfate and carboplatin
| Article | Year |
|---|---|
Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.
Topics: Carboplatin; Carrier Proteins; Chromatography, High Pressure Liquid; Cisplatin; Dialysis; Half-Life; Humans; In Vitro Techniques; Kinetics; Organoplatinum Compounds; Protein Binding; Thiosulfates; Ultrafiltration | 1986 |
In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity.
Topics: Acoustic Stimulation; Animals; Blood-Brain Barrier; Carboplatin; Carcinoma, Small Cell; Cell Line; Cell Survival; Drug Administration Schedule; Female; Furosemide; Guinea Pigs; Hair Cells, Auditory, Outer; Humans; Lung Neoplasms; Membrane Potentials; Rats; Thiosulfates; Time Factors; Tumor Cells, Cultured | 1996 |
First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate.
Topics: Adolescent; Adult; Antineoplastic Agents; Blood Glucose; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Dose-Response Relationship, Drug; Female; Hearing Disorders; Humans; Male; Middle Aged; Thiosulfates | 1998 |
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Topics: Animals; Antidotes; Auditory Threshold; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Ear, Middle; Etoposide; Female; Guinea Pigs; Humans; Lung Neoplasms; Male; Rats; Rats, Long-Evans; Rats, Nude; Thiosulfates; Tumor Cells, Cultured | 2000 |
Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Topics: Acetylcysteine; Alkylating Agents; Antimetabolites, Antineoplastic; Apoptosis; Buthionine Sulfoximine; Carboplatin; Cell Survival; Cytoprotection; Drug Interactions; Humans; Molecular Weight; Protective Agents; Thiosulfates; Time Factors; Tumor Cells, Cultured | 2001 |
Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors.
Topics: Adolescent; Adult; Aged; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Deafness; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Quality of Life; Thiosulfates; Time Factors | 2001 |
Strategies for prevention of toxicity caused by platinum-based chemotherapy: review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001.
Topics: Animals; Antineoplastic Agents; Antioxidants; Blood-Brain Barrier; Carboplatin; Cisplatin; Head and Neck Neoplasms; Hearing Loss; Humans; Methionine; Platinum Compounds; Thiosulfates | 2002 |
Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
Topics: Antineoplastic Agents; Auditory Threshold; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Chelating Agents; Child; Child, Preschool; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ependymoma; Female; Hearing Loss, Sensorineural; Humans; Infant; Infusions, Intravenous; Male; Neuroectodermal Tumors, Primitive; Survival Analysis; Thiosulfates; Time Factors | 2006 |
Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?
Topics: Antineoplastic Agents; Brain Neoplasms; Carboplatin; Chelating Agents; Child; Child, Preschool; Hearing Loss, Sensorineural; Humans; Infant; Platinum Compounds; Thiosulfates | 2006 |
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Hypoxia; Cell Line, Tumor; Cisplatin; Humans; Mice; Mice, Nude; Neuroblastoma; Radiation-Sensitizing Agents; Thiosulfates; Xenograft Model Antitumor Assays | 2008 |
Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
Topics: Animals; Antidotes; Antineoplastic Agents; Apoptosis; Biological Assay; Carboplatin; Cell Line; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Electric Impedance; Epithelial Cells; Fluorouracil; Glutathione; Humans; Kidney; Kidney Tubules; Thiosulfates | 2012 |
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Middle Aged; Mitomycin; Multivariate Analysis; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Peritoneum; Survival Analysis; Thiosulfates; Treatment Outcome; Young Adult | 2014 |